Tate & Lyle Signs Contract Manufacturing Agreement with Amyris
Tate Lyle announces that it has entered into a contract manufacturing agreement with California based Amyris, Inc. Under this agreement, Tate Lyle will produce farnesene at its facilities in Decatur, Illinois. The product will be owned and distributed by Amyris.
"We are delighted to be working with Amyris to help them achieve the first commercialization of its farnesene product," said Matt Wineinger, President, Bulk Ingredients, Tate Lyle. "The combination of Tate Lyle’s leading-edge facilities and expertise, and Amyris’ fermentation processes and equipment are a truly excellent fit.
"We are excited to be collaborating with Tate Lyle to accelerate our commercial production of farnesene," said John Melo, CEO of Amyris. "Beyond supporting our commercial production targets in 2011, we believe that this partnership will allow us to leverage Tate Lyle’s world leading expertise in aseptic fermentation operations as we ramp our industrial scale."
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
